Literature DB >> 12572852

X-chromosome inactivation and human genetic disease.

M F Lyon1.   

Abstract

UNLABELLED: The inactivation of one X-chromosome in females in early development is the process by which the effective dosage of X-linked genes is equalized between XX females and XY males. The mechanism that brings this about is the subject of intense research. The X-linked gene Xist is a key player, which is necessary but not sufficient for the initiation of X-inactivation. It codes for an untranslated RNA that coats the inactive X-chromosome, which takes on properties characteristic of heterochromatin, but how this change in chromatin is brought about remains unknown. Because of X-inactivation, females heterozygous for X-linked genes are mixtures of two types of cells and show a variable phenotype. The proportions of the two types of cells can depart from equality due to cell selection either at the tissue or whole organism level. In rare cases, changes in the Xist gene can cause skewing of X-inactivation. A few genes escape from X-inactivation either wholly or partially.
CONCLUSION: X-chromosome inactivation is a physiological mechanism that equalizes gene-dosage effects on the sex chromosomes. The occurrence of this normal process affects the phenotype seen in females carrying X-linked mutant genes or chromosome anomalies.

Entities:  

Mesh:

Year:  2002        PMID: 12572852     DOI: 10.1111/j.1651-2227.2002.tb03120.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  35 in total

1.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Extremely skewed X-chromosome inactivation is increased in pre-eclampsia.

Authors:  Elif Uz; Ismail Dolen; Atakan R Al; Tayfun Ozcelik
Journal:  Hum Genet       Date:  2006-11-07       Impact factor: 4.132

Review 3.  Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia.

Authors:  Mary C Perrin; Alan S Brown; Dolores Malaspina
Journal:  Schizophr Bull       Date:  2007-08-21       Impact factor: 9.306

Review 4.  Turner syndrome.

Authors:  Shelli R Kesler
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2007-07

Review 5.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

6.  Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

Authors:  B Hoffmann; A Garcia de Lorenzo; A Mehta; M Beck; U Widmer; R Ricci
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

7.  Sex determination from buccal mucosa scrapes.

Authors:  Tushar Mittal; K Muralidhar Saralaya; Ajee Kuruvilla; Chandrayya Achary
Journal:  Int J Legal Med       Date:  2008-09-24       Impact factor: 2.686

8.  Sex chromosome inactivation in the male.

Authors:  Wei Yan; John R McCarrey
Journal:  Epigenetics       Date:  2009-10-25       Impact factor: 4.528

9.  X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.

Authors:  Juan I Young; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

Review 10.  Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

Authors:  Louise L C Pinto; Taiane A Vieira; Roberto Giugliani; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.